Recurrent PTPN14 Mutations in Trichilemmoma: Evidence for Distinct Pathways of Molecular Pathogenesis
hosted byWolters KluwerRecurrent PTPN14 Mutations in Trichilemmoma: Evidence for Distinct Pathways of Molecular Pathogenesis is organized by Wolters Kluwer and will be held from Aug 01, 2022 - Jul 31, 2024.
Description
Method of Participation in the Learning Process/Evaluation Method
Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.
Getting the Most out of the Activity
As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.
While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.
Learning Objectives
After completing this continuing education activity you will be able to:
• Describe the histopathologic features of trichilemmoma.
• Compare and contrast pathways of the molecular pathogenesis of trichilemmoma.
• Analyze the emerging role of PTPN14 as a tumor suppressor gene.
Additional details will be posted as soon as information is available.
